Drugs / RLD
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT04080206 Comparator | Apr 2020 → Jan 2021 | psoriasis | Therapeutics, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RLD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04080206 ↗ |
| Route | Topical | “Applied topically twice daily for two weeks” NCT04080206 ↗ |